LQCL2601 - CMLE - Pheochromocytoma: Preanalytical Factors That Shape Test Results-LQCL2601

LQCL2601 - Educational Activity

Pdf Summary

This clinical chemistry case-based exercise focuses on the laboratory diagnosis of pheochromocytoma, emphasizing how pre-analytical conditions can strongly influence plasma and urinary metanephrine results. A 42-year-old patient presents with episodic headaches, palpitations, sweating, and markedly elevated in-office blood pressure, along with unexpected hyperglycemia—findings consistent with catecholamine excess. Initial plasma testing shows markedly elevated free metanephrine and especially normetanephrine, prompting the laboratory director to contact the clinician because the specimen was collected under suboptimal conditions (patient seated, visibly anxious) and while taking escitalopram, a potential interferent.<br /><br />The document explains that metanephrines (metanephrine and normetanephrine) are preferred biomarkers over parent catecholamines because tumors produce metanephrines continuously even when catecholamine secretion is episodic. It details proper collection protocols for plasma free metanephrines (fasting, avoidance of caffeine/medications, supine rest for 30 minutes, immediate chilling and rapid centrifugation) and for 24-hour urine metanephrines (acid preservation, full timed collection, refrigeration). Key causes of false positives include upright posture (raising results by ~30–40%), psychological stress/anxiety, and numerous medications and lifestyle factors (SSRIs/SNRIs, TCAs, MAOIs, adrenergic blockers, nicotine, caffeine, alcohol, exercise, recreational drugs).<br /><br />Analytically, the preferred measurement method is HPLC–MS/MS due to improved specificity and sensitivity and reduced interference compared with immunoassays. After repeat plasma collection under optimal conditions still shows persistent marked elevations, MRI identifies a right adrenal mass. Genetic testing—important because ~40% of cases are hereditary—reveals an SDHB mutation. The patient receives appropriate preoperative alpha- then beta-blockade, undergoes adrenalectomy, and metanephrines normalize postoperatively. The overall message highlights laboratory–clinical communication, rigorous pre-analytical control, and the roles of mass spectrometry and genetic testing in accurate diagnosis and management.

Keywords

pheochromocytoma

plasma free metanephrines

urinary fractionated metanephrines

pre-analytical variables

supine rest collection protocol

false-positive metanephrine elevation

medication interference (SSRIs/SNRIs)

HPLC–MS/MS mass spectrometry

SDHB mutation hereditary paraganglioma-pheochromocytoma syndrome

preoperative alpha- then beta-blockade